Stock
TFF PHARMACEUTICALS
tastytradeTrade TFFP
TFFP Insider Trades:
Created with Highcharts 10.1.0PriceVolumeJul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24-12001202403604806000200k400k600k800k1 000k1 200k






Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
Director
10% Owner
Mcap/AUM
2024-07-03
2024-07-08
KING THOMAS BRAXTON
A - Grant
Stock Options (Right to Buy)
1,583
$0.00
1
$288.8K
2024-07-03
2024-07-08
KING THOMAS BRAXTON
A - Grant
Common Stock
1,583
$0.00
1
$288.8K
2024-07-03
2024-07-08
COLEMAN KIRK ALLEN
Chief Financial Officer
A - Grant
Common Stock
10,184
$0.00
1
$288.8K
2024-07-03
2024-07-08
LEE CATHERINE CHAI-ZON
A - Grant
Stock Options (Right to Buy)
1,583
$0.00
1
$288.8K
2024-07-03
2024-07-08
LEE CATHERINE CHAI-ZON
A - Grant
Common Stock
1,583
$0.00
1
$288.8K
2024-07-03
2024-07-08
COLEMAN KIRK ALLEN
Chief Financial Officer
A - Grant
Stock Options (Right to Buy)
10,184
$0.00
1
$288.8K
2024-07-03
2024-07-08
MIKHAK ZAMANEH
Chief Medical Officer
A - Grant
Stock Options (Right to Buy)
10,184
$0.00
1
$288.8K
2024-07-03
2024-07-08
MIKHAK ZAMANEH
Chief Medical Officer
A - Grant
Common Stock
10,184
$0.00
1
$288.8K
2024-07-03
2024-07-08
MILLS ROBERT
A - Grant
Stock Options (Right to Buy)
3,165
$0.00
1
$288.8K
2024-07-03
2024-07-08
MILLS ROBERT
A - Grant
Common Stock
3,165
$0.00
1
$288.8K
2024-07-03
2024-07-08
ROBERTS BRANDI
A - Grant
Stock Options (Right to Buy)
3,165
$0.00
1
$288.8K
2024-07-03
2024-07-08
ROBERTS BRANDI
A - Grant
Common Stock
3,165
$0.00
1
$288.8K
2024-07-03
2024-07-08
ROCAMBOLI STEPHEN
A - Grant
Stock Options (Right to Buy)
3,165
$0.00
1
$288.8K
2024-07-03
2024-07-08
ROCAMBOLI STEPHEN
A - Grant
Common Stock
3,165
$0.00
1
$288.8K
2024-07-03
2024-07-08
WEISMAN HARLAN
President and CEO
A - Grant
Stock Options (Right to Buy)
27,480
$0.00
1
$288.8K
2024-07-03
2024-07-08
WEISMAN HARLAN
President and CEO
A - Grant
Common Stock
27,480
$0.00
1
$288.8K
2024-04-18
2024-04-22
COLEMAN KIRK ALLEN
Chief Financial Officer
A - Grant
Restricted stock units
15,900
$0.00
2
$288.8K
2024-04-18
2024-04-22
KING THOMAS BRAXTON
A - Grant
Restricted stock units
3,110
$0.00
1
$288.8K
2024-04-18
2024-04-22
LEE CATHERINE CHAI-ZON
A - Grant
Restricted stock units
3,556
$0.00
1
$288.8K
2024-04-18
2024-04-22
MIKHAK ZAMANEH
Chief Medical Officer
A - Grant
Restricted stock units
15,900
$0.00
2
$288.8K
2024-04-18
2024-04-22
MILLS ROBERT
A - Grant
Restricted stock units
4,667
$0.00
1
$288.8K
2024-04-18
2024-04-22
PATANE MICHAEL
A - Grant
Restricted stock units
3,556
$0.00
1
$288.8K
2024-04-18
2024-04-22
ROBERTS BRANDI
A - Grant
Restricted stock units
5,333
$0.00
1
$288.8K
2024-04-18
2024-04-22
ROCAMBOLI STEPHEN
A - Grant
Restricted stock units
4,667
$0.00
1
$288.8K
2024-04-18
2024-04-22
WEISMAN HARLAN
President and CEO
A - Grant
Restricted stock units
44,967
$0.00
1
$288.8K
2023-12-13
2023-12-15
KING THOMAS BRAXTON
A - Grant
Stock Options (Right to Buy)
132K
$0.00
1
$288.8K
2023-12-01
2023-12-04
LEE CATHERINE CHAI-ZON
A - Grant
Stock Options (Right to Buy)
132K
$0.00
1
$288.8K
2023-12-01
2023-12-04
MILLS ROBERT
A - Grant
Stock Options (Right to Buy)
52,858
$0.00
1
$288.8K
2023-12-01
2023-12-04
PATANE MICHAEL
A - Grant
Stock Options (Right to Buy)
132K
$0.00
1
$288.8K
2023-12-01
2023-12-04
ROBERTS BRANDI
A - Grant
Stock Options (Right to Buy)
52,858
$0.00
1
$288.8K
2023-12-01
2023-12-04
ROCAMBOLI STEPHEN
A - Grant
Stock Options (Right to Buy)
52,858
$0.00
1
$288.8K
2023-08-16
2023-08-17
CARLSON CAPITAL
S - Sale
Common Stock
-1,000
$0.00
1
$288.8K
2023-08-15
2023-08-17
CARLSON CAPITAL
S - Sale
Common Stock, par value $0.001 per share (the "Common Stock"
-215K
$0.00
1
$288.8K
2023-08-15
2023-08-15
MILLS ROBERT
P - Purchase
Common Stock
40,000
$0.00
1
$288.8K
2023-08-15
2023-08-15
COLEMAN KIRK ALLEN
Chief Financial Officer
P - Purchase
Common Stock
20,000
$0.00
1
$288.8K
2023-08-15
2023-08-15
MIKHAK ZAMANEH
Chief Medical Officer
P - Purchase
Common Stock
120K
$0.00
1
$288.8K
2023-08-15
2023-08-15
ROBERTS BRANDI
P - Purchase
Common Stock
20,000
$0.00
1
$288.8K
2023-08-15
2023-08-15
ROCAMBOLI STEPHEN
P - Purchase
Common Stock
20,000
$0.00
1
$288.8K
2023-08-15
2023-08-15
WEISMAN HARLAN
President and CEO
P - Purchase
Common Stock
600K
$0.00
1
$288.8K
2023-03-22
2023-03-24
COLEMAN KIRK ALLEN
Chief Financial Officer
A - Grant
Stock Options (Right to Buy)
100K
$0.00
1
$288.8K
2023-03-10
2023-03-13
COLEMAN KIRK ALLEN
Chief Financial Officer
P - Purchase
Common Stock
12,000
$1.00
12,000
1
$288.8K
2023-03-10
2023-03-13
MIKHAK ZAMANEH
Chief Medical Officer
P - Purchase
Common Stock
15,000
$1.00
15,000
1
$288.8K
2023-03-10
2023-03-13
ROCAMBOLI STEPHEN
P - Purchase
Common Stock
13,000
$1.00
13,000
1
$288.8K
2023-03-10
2023-03-13
WEISMAN HARLAN
President and CEO
P - Purchase
Common Stock
150K
$1.00
150K
1
$288.8K
2022-12-29
2022-12-30
ROCAMBOLI STEPHEN
A - Grant
Stock Options (Right to Buy)
33,475
$0.00
1
$288.8K
2022-12-29
2022-12-30
FLETCHER AARON G.L.
A - Grant
Stock Options (Right to Buy)
33,475
$0.00
1
$288.8K
2022-12-29
2022-12-30
MILLS ROBERT
A - Grant
Stock Options (Right to Buy)
33,475
$0.00
1
$288.8K
2022-12-29
2022-12-30
ROBERTS BRANDI
A - Grant
Stock Options (Right to Buy)
20,968
$0.00
1
$288.8K
2022-12-15
2022-12-19
WEISMAN HARLAN
President and CEO
P - Purchase
Common Stock
50,000
$1.00
50,000
1
$288.8K
2022-12-03
2022-12-06
WEISMAN HARLAN
President and CEO
A - Grant
Stock Options (Right to Buy)
1.79M
$0.00
1
$288.8K
2022-11-22
2022-11-23
FLETCHER AARON G.L.
P - Purchase
Common Stock Purchase Warrants
21,735
$0.00
1
$288.8K
2022-11-22
2022-11-23
FLETCHER AARON G.L.
P - Purchase
Common Stock
43,470
$1.00
43,470
1
$288.8K
2022-09-29
2022-09-30
THURMAN RANDY
M - Exercise
Stock Options (Right to Buy)
-40,255
$0.00
1
$288.8K
2022-09-29
2022-09-30
THURMAN RANDY
M - Exercise
Common Stock
40,255
$3.00
121K
1
$288.8K
2022-09-29
2022-09-30
THURMAN RANDY
S - Sale
Common Stock
-40,255
$4.00
-161K
1
$288.8K
2022-05-20
2022-05-20
WEISMAN HARLAN
P - Purchase
Common Stock
4,615
$6.00
27,690
1
$288.8K
2022-05-18
2022-05-20
WEISMAN HARLAN
P - Purchase
Common Stock
2,500
$5.00
12,500
1
$288.8K
2022-05-17
2022-05-17
COLEMAN KIRK ALLEN
Chief Financial Officer
P - Purchase
Common Stock
425
$5.00
2,125
1
$288.8K
2022-05-17
2022-05-17
FLETCHER AARON G.L.
P - Purchase
Common Stock
24,600
$5.00
123K
1
$288.8K
2022-05-16
2022-05-17
MATTES GLENN
President and CEO
P - Purchase
Common Stock
16,000
$5.00
80,000
1
$288.8K
2022-05-16
2022-05-17
COLEMAN KIRK ALLEN
Chief Financial Officer
P - Purchase
Common Stock
1,250
$4.00
5,000
1
$288.8K
2022-05-16
2022-05-17
WEISMAN HARLAN
P - Purchase
Common Stock
2,500
$5.00
12,500
1
$288.8K
2022-05-16
2022-05-17
ROCAMBOLI STEPHEN
P - Purchase
Common Stock
3,000
$5.00
15,000
1
$288.8K
2022-05-16
2022-05-17
FLETCHER AARON G.L.
P - Purchase
Common Stock
85,000
$5.00
425K
1
$288.8K
2022-04-04
2022-04-04
FLETCHER AARON G.L.
P - Purchase
Common Stock
542K
$6.00
3.25M
2
$288.8K
2021-09-22
2021-09-24
CANO CHRISTOPHER
Chief Operating Officer
A - Grant
Stock Option (Right to Buy)
43,000
$0.00
1
$288.8K
2021-09-16
2021-09-16
COLEMAN KIRK ALLEN
CFO, Secretary and Treasurer
P - Purchase
Common Stock
1,000
$7.00
7,000
1
$288.8K
2021-09-16
2021-09-16
MATTES GLENN
President and CEO
P - Purchase
Common Stock
10,000
$7.00
70,000
1
$288.8K
2021-05-19
2021-05-19
FAIRBAIRN MALCOLM
P - Purchase
Common Stock
10,000
$9.00
90,000
1
$288.8K
2021-05-18
2021-05-19
THURMAN RANDY
P - Purchase
Common Stock
1,050
$9.00
9,450
1
$288.8K
2021-03-26
2021-03-30
LUNG THERAPEUTICS, INC.
S - Sale
Common Stock
-715K
$14.00
-10M
1
$288.8K
2021-03-15
2021-03-17
ROCAMBOLI STEPHEN
M - Exercise
Common Stock
20,006
$3.00
60,018
2
$288.8K
2021-03-15
2021-03-17
COLEMAN KIRK ALLEN
CFO, Secretary and Treasurer
M - Exercise
Stock Options (Right to Buy)
-5,000
$0.00
1
$288.8K
2021-03-15
2021-03-17
COLEMAN KIRK ALLEN
CFO, Secretary and Treasurer
M - Exercise
Common Stock
5,000
$3.00
15,000
1
$288.8K
2021-03-15
2021-03-17
MATTES GLENN
President and CEO
M - Exercise
Stock Options (Right to Buy)
-50,000
$0.00
1
$288.8K
2021-03-15
2021-03-17
MATTES GLENN
President and CEO
M - Exercise
Common Stock
50,000
$3.00
150K
1
$288.8K
2021-03-15
2021-03-17
ROCAMBOLI STEPHEN
M - Exercise
Stock Options (Right to Buy)
-20,006
$0.00
2
$288.8K
2021-03-15
2021-03-17
COLEMAN KIRK ALLEN
CFO, Secretary and Treasurer
S - Sale
Common Stock
-5,000
$17.00
-85,000
1
$288.8K
2021-03-15
2021-03-17
MATTES GLENN
President and CEO
S - Sale
Common Stock
-50,000
$17.00
-850K
1
$288.8K
2021-03-15
2021-03-17
ROCAMBOLI STEPHEN
S - Sale
Common Stock
-20,006
$17.00
-340K
1
$288.8K
2021-02-16
2021-02-18
COLEMAN KIRK ALLEN
CFO, Secretary and Treasurer
M - Exercise
Stock Options (Right to Buy)
-5,000
$0.00
1
$288.8K
2021-02-16
2021-02-18
COLEMAN KIRK ALLEN
CFO, Secretary and Treasurer
M - Exercise
Common Stock
5,000
$3.00
15,000
1
$288.8K
2021-02-16
2021-02-18
MATTES GLENN
President and CEO
M - Exercise
Stock Options (Right to Buy)
-40,000
$0.00
1
$288.8K
2021-02-16
2021-02-18
MATTES GLENN
President and CEO
M - Exercise
Common Stock
40,000
$3.00
120K
1
$288.8K
2021-02-16
2021-02-18
COLEMAN KIRK ALLEN
CFO, Secretary and Treasurer
S - Sale
Common Stock
-5,000
$17.00
-85,000
1
$288.8K
2021-02-16
2021-02-18
MATTES GLENN
President and CEO
S - Sale
Common Stock
-40,000
$17.00
-680K
1
$288.8K
2021-02-10
2021-02-12
MILLS ROBERT
M - Exercise
Stock Options (Right to Buy)
-700
$0.00
1
$288.8K
2021-02-10
2021-02-12
MILLS ROBERT
M - Exercise
Common Stock
700
$3.00
2,100
1
$288.8K
2021-02-10
2021-02-12
MILLS ROBERT
S - Sale
Common Stock
-700
$20.00
-14,000
1
$288.8K
2021-01-20
2021-01-20
MILLS ROBERT
M - Exercise
Stock Options (Right to Buy)
-12,600
$0.00
1
$288.8K
2021-01-20
2021-01-20
MILLS ROBERT
M - Exercise
Common Stock
12,600
$3.00
37,800
1
$288.8K
2021-01-20
2021-01-20
MILLS ROBERT
S - Sale
Common Stock
-12,600
$20.00
-252K
1
$288.8K
2021-01-19
2021-01-20
MILLS ROBERT
M - Exercise
Stock Options (Right to Buy)
-55,100
$0.00
1
$288.8K
2021-01-19
2021-01-20
MILLS ROBERT
M - Exercise
Common Stock
55,100
$3.00
165K
1
$288.8K
2021-01-19
2021-01-20
MILLS ROBERT
S - Sale
Common Stock
-55,100
$20.00
-1.10M
1
$288.8K
2021-01-15
2021-01-20
MATTES GLENN
President and CEO
S - Sale
Common Stock
-40,000
$18.00
-720K
1
$288.8K
2021-01-15
2021-01-20
MATTES GLENN
President and CEO
M - Exercise
Stock Options (Right to Buy)
-40,000
$0.00
1
$288.8K
2021-01-15
2021-01-20
MATTES GLENN
President and CEO
M - Exercise
Common Stock
40,000
$3.00
120K
1
$288.8K
2021-01-15
2021-01-20
COLEMAN KIRK ALLEN
CFO, Secretary and Treasurer
S - Sale
Common Stock
-5,000
$18.00
-90,000
1
$288.8K
2021-01-15
2021-01-20
COLEMAN KIRK ALLEN
CFO, Secretary and Treasurer
M - Exercise
Stock Options (Right to Buy)
-5,000
$0.00
1
$288.8K
2021-01-15
2021-01-20
COLEMAN KIRK ALLEN
CFO, Secretary and Treasurer
M - Exercise
Common Stock
5,000
$3.00
15,000
1
$288.8K
2020-09-25
2021-01-20
MATTES GLENN
President and CEO
S - Sale
Common Stock
-3,000
$17.00
-51,000
1
$288.8K
2020-12-23
2020-12-29
COLEMAN KIRK ALLEN
CFO, Secretary and Treasurer
M - Exercise
Stock Options (Right to Buy)
-10,000
$0.00
1
$288.8K
2020-12-23
2020-12-29
COLEMAN KIRK ALLEN
CFO, Secretary and Treasurer
M - Exercise
Common Stock
10,000
$3.00
30,000
1
$288.8K
2020-12-23
2020-12-29
MATTES GLENN
President and CEO
M - Exercise
Stock Options (Right to Buy)
-30,000
$0.00
1
$288.8K
2020-12-23
2020-12-29
MATTES GLENN
President and CEO
M - Exercise
Common Stock
30,000
$3.00
90,000
1
$288.8K
2020-12-23
2020-12-29
COLEMAN KIRK ALLEN
CFO, Secretary and Treasurer
S - Sale
Common Stock
-10,000
$15.00
-150K
1
$288.8K
2020-12-23
2020-12-29
MATTES GLENN
President and CEO
S - Sale
Common Stock
-30,000
$15.00
-450K
1
$288.8K
2020-12-11
2020-12-15
MILLS ROBERT
M - Exercise
Stock Options (Right to Buy)
-22,794
$0.00
1
$288.8K
2020-12-11
2020-12-15
MILLS ROBERT
M - Exercise
Common Stock
22,794
$3.00
68,382
1
$288.8K
2020-12-11
2020-12-15
MILLS ROBERT
S - Sale
Common Stock
-22,794
$15.00
-342K
1
$288.8K
2020-12-07
2020-12-09
WINDSOR JAMES BRIAN
Chief Science Officer
M - Exercise
Stock Options (Right to Buy)
-25,000
$0.00
1
$288.8K
2020-12-07
2020-12-09
WINDSOR JAMES BRIAN
Chief Science Officer
M - Exercise
Common Stock
25,000
$3.00
75,000
1
$288.8K
2020-12-07
2020-12-09
WINDSOR JAMES BRIAN
Chief Science Officer
S - Sale
Common Stock
-25,000
$16.00
-400K
1
$288.8K
2020-12-04
2020-12-08
LUNG THERAPEUTICS, INC.
S - Sale
Common Stock
-1.05M
$14.00
-15M
3
$288.8K
2020-11-24
2020-11-24
FLETCHER AARON G.L.
P - Purchase
Common Stock
5,000
$15.00
75,000
1
$288.8K
2020-11-13
2020-11-13
THURMAN RANDY
S - Sale
Common Stock
-5,000
$17.00
-85,000
1
$288.8K
2020-11-12
2020-11-13
FAIRBAIRN MALCOLM
S - Sale
Common Stock
-11,669
$16.00
-187K
1
$288.8K
2020-11-11
2020-11-13
ROCAMBOLI STEPHEN
M - Exercise
Stock Options (Right to Buy)
-15,722
$0.00
1
$288.8K
2020-11-11
2020-11-13
ROCAMBOLI STEPHEN
M - Exercise
Common Stock
15,722
$3.00
47,166
1
$288.8K
2020-11-11
2020-11-13
THURMAN RANDY
M - Exercise
Stock Options (Right to Buy)
-34,504
$0.00
1
$288.8K
2020-11-11
2020-11-13
THURMAN RANDY
M - Exercise
Common Stock
34,504
$3.00
104K
1
$288.8K
2020-11-11
2020-11-13
FAIRBAIRN MALCOLM
S - Sale
Common Stock
-63,331
$16.00
-1.01M
1
$288.8K
2020-11-11
2020-11-13
ROCAMBOLI STEPHEN
S - Sale
Common Stock
-15,722
$16.00
-252K
1
$288.8K
2020-11-11
2020-11-13
THURMAN RANDY
S - Sale
Common Stock
-34,504
$16.00
-552K
1
$288.8K
2020-11-10
2020-11-13
MATTES GLENN
President and CEO
M - Exercise
Stock Options (Right to Buy)
-109K
$0.00
1
$288.8K
2020-11-10
2020-11-13
COLEMAN KIRK ALLEN
CFO, Secretary, and Treasurer
M - Exercise
Common Stock
15,000
$3.00
45,000
1
$288.8K
2020-11-10
2020-11-13
COLEMAN KIRK ALLEN
CFO, Secretary, and Treasurer
M - Exercise
Stock Options (Right to Buy)
-15,000
$0.00
1
$288.8K
2020-11-10
2020-11-13
MATTES GLENN
President and CEO
M - Exercise
Common Stock
109K
$3.00
326K
1
$288.8K
2020-11-10
2020-11-13
ROCAMBOLI STEPHEN
M - Exercise
Stock Options (Right to Buy)
-21,278
$0.00
1
$288.8K
2020-11-10
2020-11-13
ROCAMBOLI STEPHEN
M - Exercise
Common Stock
21,278
$3.00
63,834
1
$288.8K
2020-11-10
2020-11-13
COLEMAN KIRK ALLEN
CFO, Secretary, and Treasurer
S - Sale
Common Stock
-15,000
$15.00
-225K
1
$288.8K
2020-11-10
2020-11-13
MATTES GLENN
President and CEO
S - Sale
Common Stock
-109K
$15.00
-1.63M
1
$288.8K
2020-11-10
2020-11-13
ROCAMBOLI STEPHEN
S - Sale
Common Stock
-21,278
$15.00
-319K
1
$288.8K
2020-08-24
2020-08-26
WEISMAN HARLAN
A - Grant
Stock Options (Right to Buy)
20,000
$0.00
1
$288.8K
2020-08-24
2020-08-26
WINDSOR JAMES BRIAN
Chief Science Officer
A - Grant
Stock Options (Right to Buy)
20,000
$0.00
1
$288.8K
2020-08-24
2020-08-26
COLEMAN KIRK ALLEN
CFO, Secretary, and Treasurer
A - Grant
Stock Options (Right to Buy)
40,000
$0.00
1
$288.8K
2020-08-24
2020-08-26
FAIRBAIRN MALCOLM
A - Grant
Stock Options (Right to Buy)
13,200
$0.00
1
$288.8K
2020-08-24
2020-08-26
FLETCHER AARON G.L.
A - Grant
Stock Options (Right to Purchase)
20,000
$0.00
1
$288.8K
2020-08-24
2020-08-26
MATTES GLENN
President and CEO
A - Grant
Stock Options (Right to Buy)
152K
$0.00
1
$288.8K
2020-08-24
2020-08-26
MILLS ROBERT
A - Grant
Stock Options (Right to Buy)
30,300
$0.00
1
$288.8K
2020-08-24
2020-08-26
ROCAMBOLI STEPHEN
A - Grant
Stock Options (Right to Buy)
20,000
$0.00
1
$288.8K
2020-08-24
2020-08-26
THURMAN RANDY
A - Grant
Stock Options (Right to Buy)
20,000
$0.00
1
$288.8K
2019-11-29
2020-08-26
MATTES GLENN
President and CEO
A - Grant
Stock Options (Right to Buy)
89,952
$0.00
1
$288.8K
2019-11-29
2020-08-26
MILLS ROBERT
A - Grant
Stock Options (Right to Buy)
25,838
$0.00
1
$288.8K
2020-05-26
2020-05-26
FLETCHER AARON G.L.
P - Purchase
Common Stock
20,000
$5.00
100K
1
$288.8K
2020-04-15
2020-04-17
FLETCHER AARON G.L.
P - Purchase
Common Stock
5,581
$5.00
27,905
1
$288.8K
2020-04-06
2020-04-06
FLETCHER AARON G.L.
P - Purchase
Common Stock
6,252
$4.00
25,008
1
$288.8K
2020-04-03
2020-04-06
FLETCHER AARON G.L.
P - Purchase
Common Stock
16,748
$4.00
66,992
1
$288.8K
2020-04-02
2020-04-06
FLETCHER AARON G.L.
P - Purchase
Common Stock
500
$4.00
2,000
1
$288.8K
2020-02-14
2020-02-19
FAIRBAIRN MALCOLM
A - Grant
Stock Options (Right to Buy)
92,255
$0.00
1
$288.8K
2019-12-20
2019-12-26
COLEMAN KIRK ALLEN
CFO, Secretary, and Treasurer
A - Grant
Stock Options (Right to Buy)
50,000
$0.00
1
$288.8K